Anticipated Phase 3 Trial of Hydronidone for Treating Liver Fibrosis in Chronic Hepatitis B
Chronic Hepatitis B virus symbol. Image credits: Unsplash A multicenter Phase 3 clinical trial is underway to evaluate the efficacy of hydronidone, a novel antifibrotic agent, in reversing liver fibrosis among patients with chronic hepatitis B (CHB). The study, conducted across 44 centers in China, investigates whether a 270 mg/day dose of hydronidone, when added […]
Panther’s Microarray Patch Offers Novel Therapy Delivery System for Potential Infectious Disease Applications
In a previous life, Matthew Hepburn, MD, an infectious disease physician, worked with the Biden and Trump Administrations, and held the role of vaccine development lead for Operation Warp Speed, which was instrumental in developing COVID-19 vaccines in less than a year. This task was monumental considering it typically takes years to develop vaccines, and […]
Americans don’t think bird flu is a threat, study suggests
In an editorial in the American Journal of Public Health, a team led by researchers from the CUNY Graduate School of Public Health and Health Policy (CUNY SPH) say public ignorance and apathy towards bird flu (highly pathogenic avian influenza, or HPAI) could pose a serious obstacle to containing the virus and preventing a larger-scale […]
Candida auris Epidemiology and Resistance Mechanisms Challenge Antifungal Treatment and Surveillance
This is a medical illustration of Candida auris fungal organisms, presented in the CDC publication entitled, Antibiotic Resistance Threats in the United States, 2019. Image Credit: CDC, Stephanie Rossow In a recent Nature editorial, C auris is highlighted as an emerging multidrug‑resistant yeast that has drawn urgent attention from global and UK health authorities amid […]
Experts Say CDC Cuts Will Cost Lives
This Medical News article discusses how recent workforce and program reductions at the US Centers for Disease Control and Prevention will affect public health. Source link
